Investment Analysts’ Updated EPS Estimates for January 10th (BHP, BP, CBOE, CETX, DYN, IMAX, INZY, IRON, ITOS, JKS)

Investment Analysts’ updated eps estimates for Friday, January 10th:

BHP Group (NYSE:BHP) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating.

BP (NYSE:BP) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Cboe Global Markets (NASDAQ:CBOE) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

Cemtrex (NASDAQ:CETX) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Dyne Therapeutics (NASDAQ:DYN) had its buy rating reaffirmed by analysts at Chardan Capital. Chardan Capital currently has a $50.00 price target on the stock.

IMAX (NYSE:IMAX) had its outperform rating reissued by analysts at Barrington Research. They currently have a $30.00 target price on the stock.

Inozyme Pharma (NASDAQ:INZY) had its outperform rating reissued by analysts at Wedbush. Wedbush currently has a $12.00 target price on the stock.

Disc Medicine (NASDAQ:IRON) had its outperform rating reiterated by analysts at Wedbush. Wedbush currently has a $83.00 price target on the stock.

iTeos Therapeutics (NASDAQ:ITOS) had its outperform rating reissued by analysts at Wedbush. They currently have a $25.00 target price on the stock.

JinkoSolar (NYSE:JKS) was downgraded by analysts at Daiwa Capital Markets from an underperform rating to a sell rating.

Mersana Therapeutics (NASDAQ:MRSN) had its outperform rating reissued by analysts at Wedbush. The firm currently has a $4.00 target price on the stock, down from their previous target price of $7.00.

New Jersey Resources (NYSE:NJR) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

Intellia Therapeutics (NASDAQ:NTLA) had its neutral rating reiterated by analysts at Wedbush. They currently have a $10.00 target price on the stock, down from their previous target price of $14.00.

Pure Cycle (NASDAQ:PCYO) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

PriceSmart (NASDAQ:PSMT) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

Saratoga Investment (NYSE:SAR) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

TD SYNNEX (NYSE:SNX) was upgraded by analysts at Cfra from a hold rating to a buy rating. Cfra currently has $147.00 price target on the stock, up from their previous price target of $122.00.

Y-mAbs Therapeutics (NASDAQ:YMAB) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $23.00 price target on the stock.